Barclays lowered the firm’s price target on Skyward Specialty Insurance (SKWD) to $57 from $63 and keeps an Overweight rating on the shares. The firm adjusted targets in the insurance group as part of a Q1 preview. Premium growth and broker organic growth “are likely to remain sluggish,” the analyst tells investors in a research note. However, Barclays sees solid margins and strong capital deployment still contributing to reported book value growth in Q1.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKWD:
- Skyward Specialty Insurance price target lowered to $65 from $70 at Keefe Bruyette
- Skyward Specialty Insurance management to meet with Citizens
- Skyward Specialty Shines With Record Earnings Momentum
- Skyward Specialty’s Apollo Deal Faces Integration, Accounting, and Regulatory Risks That Could Weigh on Financial Performance
- Skyward Specialty Insurance price target raised to $70 from $69 at Keefe Bruyette
